S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation

European Journal of Cancer

Volumn 40, Issue 8, 2004, Pages 1179-1187

  Arai, K ^a   Teratani, T ^b   Kuruto Niwa, R ^c   Yamada, T ^a   Nozawa, R ^c  

^a SHIZUOKA GENERAL HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Adenocarcinoma; Breast; Immunohistochemistry; Polymerase chain reaction; S100 protein; S100A9; Tumour differentiation

Indexed keywords

PROTEIN S 100; S100 A9 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOMA; BREAST DUCT; CARCINOMA CELL; CARCINOMA IN SITU; CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLOGY; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MITOSIS RATE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; BREAST NEOPLASMS; CALGRANULIN B; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 1942424110     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.01.022     Document Type: Article

References (31)

1. Heizmann C.W., Fritz G., Schäfer B.W. S100 proteins. structure, functions and pathology Front. Biosci. 7:2002;1356-1368.
2. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim. Biophys. Acta. 1450:1999;191-231.
3. Teratani T., Watanabe T., Kuwahara F.et al. Induced transcriptional expression of calcium-binding protein S100A1 and S100A10 genes in human renal cell carcinoma. Cancer Lett. 175:2002;71-77.
4. Ilg E.C., Schäfer B.W., Heizmann C.W. Expression pattern of S100 calcium-binding proteins in human tumors. Int. J. Cancer. 68:1996;325-332.
5. El-RiFai W., Moskaluk C.A., Abdrabbo M.K.et al. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res. 62:2002;6823-6826.
6. Teratani T., Watanabe T., Yamahara K.et al. Restricted expression of calcium-binding protein S100A5 in human kidney. Biochem. Biophys. Res. Commun. 291:2002;623-627.
7. Rosty C., Ueki T., Argani P.et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am. J. Pathol. 160:2002;45-50.
8. Rudland P.S., Platt-Higgins A., Renshaw C.et al. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res. 60:2000;1595-1603.
9. Odink K., Cerletti N., Brüggen J.et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature. 330:1987;80-82.
10. Nozawa R., Kato H., Ito T., Yokota T. Identification and characterization of a differentiation antigen in human neutrophils and monocytes. Blood. 71:1988;1288-1294.
11. Arai K., Mizuno K., Yamada T., Nozawa R. Immunohistochemical evaluation of MRP-14 expression in epithelioid granuloma using monoclonal antibody 60B8. J. Investig. Allergol. and Clin. Immunol. 9:1999;21-26.
12. Brandtzaeg P., Dale I., Fagerhol M.K. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. normal and aberrant occurrence in various epithelia. Am. J. Clin. Pathol. 87:1987;700-707.
13. Wilkinson M.M., Busuttil A., Hayward C., Brock D.J.H., Dorin J.R., van Heyningen V. Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues. J. Cell Sci. 91:1988;221-230.
14. Goebeler M., Roth J., van den Bos C., Ader G., Sorg C. Increase of calcium levels in epithelial cells induces translocation of calcium-binding proteins migration inhibitory facter-related protein 8(MRP8) and MRP14 to keratin intermediate filaments. Biochem. J. 309:1995;419-424.
15. Matsumoto T., Murao S., Kito K., Kihara T., Matsuura S., Ueda N. Modulation of S-100 genes response to growth conditions in human epithelial tumor cells. Pathol. Int. 47:1997;339-346.
16. Arai K., Teratani T., Nozawa R., Yamada T. Immunohistochemical Investigation of S100A9 expression in pulmonary adenocarcinomas. S100A9 expression is associated with tumor differentiation Oncol. Rep. 8:2001;591-596.
17. Arai K., Yamada T., Nozawa R. Immunohistochemical investigation of migration inhibitory factor-related protein(MRP)-14 expression in hepatocellular carcinoma. Med. Oncol. 17:2000;183-188.
18. Showji Y., Nozawa R., Sato K., Suzuki H. Seroprevalence of Helicobacter pylori infection in patients with connective tissue diseases. Microbiol. Immunol. 40:1996;499-503.
19. World Health Organization Histological Typing of Breast Tumours. International Histological Classification of Tumours No. 2. 2nd edn. 1981;WHO, Geneva.
20. Elton C.W., Ellis I.O. Pathological prognostic factors in breast cancer. I. the value of histological grade in breast cancer. experience from a large study with long-term follow-up Histopathology. 19:1991;403-410.
21. Dunne B., Going J.J. Scoring nuclear pleomorphism in breast cancer. Histopathology. 39:2001;259-265.
22. Theissig F., Kunze K.D., Haroske G., Meyer W. Histological grading of breast cancer. interobserver, reproducibility and prognostic significance Path. Res. Pract. 186:1990;732-736.
23. Invasive lobular carcinoma. In: Rosen PP, Oberman HA, eds. Atlas of Tumor Pathology: Tumors of the Mammary Gland, 3rd series, Fascile 7. Armed Forces Institute of Pathology, Washington DC, 1993, pp. 168-175.
24. Weidner N., Semple J.P. Pleomorphic variant of invasive lobular carcinoma of the breast. Hum. Pathol. 23:1992;1167-1171.
25. Holland R., Peterse J.L., Millis R.R.et al. Ductal carcinoma in situ. a proposal for a new classification Semin. Diagn. Pathol. 11:1994;167-180.
26. Dwarakanath S., Lee A.K.C., Delellis R.A., Silverman N.L., Frasca L., Wolfe H.J. S-100 protein positivity in breast carcinomas. a potential pitfall in diagnostic immunohistochemistry Hum. Pathol. 18:1987;1144-1148.
27. Al-Haddad S., Zhang Z., Leygue E.et al. Psoriasin (S100A7) expression and invasive breast cancer. Am. J. Pathol. 155:1999;2057-2066.
28. Pedersen K.B., Nesland J.M., Fodstad Ø., Maelandsmo G.M. Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies. Br. J. Cancer. 87:2002;1281-1286.
29. Schaafsma H.E., Ramaekers F.C.S. Cytokeratin subtyping in normal and neoplastic epithelium. basic principles and diagnostic applications Pathol. Annu. 29:1994;21-62.
30. Moll R. Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Herrmann H., Harris J.R. Subcellular Biochemistry. Intermediate Filaments:1998;205-262 Plenum, London.
31. Malzahn K., Mitze M., Thoenes M., Moll R. Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal carcinomas. Virchows Arch. 433:1998;119-129.